Low-dose aspirin and risk of upper/lower gastrointestinal bleeding by bleed severity: a cohort study with nested case-control analysis using primary care electronic health records from the United Kingdom

Incidence of Upper and Lower Gastrointestinal Bleeding in New Users of Low-dose Aspirin

(2018) Lucía Cea Soriano et al.   Clinical Gastroenterology and Hepatology

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial

(2018) J Michael Gaziano et al.   LANCET

Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

(2018) John J. McNeil et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

More Evidence to Help Guide Decision Making About Aspirin for Primary Prevention

(2018) Michael Pignone et al.   ANNALS OF INTERNAL MEDICINE

Low-dose aspirin and risk of intracranial bleeds

(2017) Lucía Cea Soriano et al.   NEUROLOGY

Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force

(2016) Evelyn P. Whitlock et al.   ANNALS OF INTERNAL MEDICINE

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2016) Kirsten Bibbins-Domingo et al.   ANNALS OF INTERNAL MEDICINE

Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses

(2016) Antonio González-Pérez et al.   BMC Cardiovascular Disorders

Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk

(2016) Peter C. Elwood et al.   PLoS One

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

(2015) Marco Roffi et al.   EUROPEAN HEART JOURNAL

Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?

(2015) Lucía Cea Soriano et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Aspirin Therapy in Primary Cardiovascular Disease Prevention

(2014) Sigrun Halvorsen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: Risk of coronary events and peptic ulcer bleeding

(2013) Luis Rodríguez et al.   THROMBOSIS AND HAEMOSTASIS

Primary and Secondary Prevention of Cardiovascular Disease

(2012) Per Olav Vandvik et al.   CHEST

Long-Term Use of Aspirin and the Risk of Gastrointestinal Bleeding

(2011) Edward S. Huang et al.   AMERICAN JOURNAL OF MEDICINE

Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications

(2011) Luis A. García Rodríguez et al.   CIRCULATION

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

(2010) Peter M Rothwell et al.   LANCET

A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men

(2010) Edward S. Huang et al.   PLoS One

Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes

(2010) Lucía Cea Soriano et al.   Frontiers in Pharmacology

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer

(2009) Andrea V. Margulis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY